Health & Medicine
-
Dr. Joseph Sparano, TAILORx Lead Author, and the Trial That Spared Many Women Chemotherapy
NEW YORK, July 17 — A landmark clinical trial that reshaped how oncologists treat early-stage breast cancer has its roots in the…
-
Bedford Artist, 21, Dies of Glioblastoma Weeks After First CT Scan Showed Nothing
WASHINGTON, July 17 — Tyler Morton’s first CT scan did not show the brain lesion that later appeared on a second CT…
-
Oncotype DX Evidence: What TAILORx and NCCN Ratings Show
WASHINGTON, July 17 — The strategic calculus of breast cancer treatment has shifted decisively over the past two decades, driven by a…
-
Oncotype DX Gene Test Spares Many Breast Cancer Patients From Chemotherapy
MADISON, Wisconsin, July 17 — The genomic test Oncotype DX has fundamentally altered the strategic calculus of breast cancer treatment, shifting the…
-
Delphi Diagnostics Offers Endocrine Activity Index Test for Stage II-III Breast Cancer
LONDON, July 17 — The genomic test that changed how oncologists decide whether to give chemotherapy for early breast cancer now has…
-
Trethera Tests Investigational Drug TRE-515 Targeting dCK
LOS ANGELES, July 17 — On the sixth floor of a modest research building near the UCLA campus, a small biotech company…
-
Harvard Retracts Cancer Paper Over Image Duplication
BOSTON, July 17 — On the ground at Brigham and Women’s Hospital, a team of researchers has lost a published paper after…
-
Glioblastoma patient sells home to fund life-extending treatment
LONDON, July 17 — Jo Fuller sold her house to fund potentially life-extending treatment for glioblastoma, an aggressive brain cancer that is…
-
Inkjet Technology May One Day Help Build Living Human Tissue
ISLAMABAD, July 17 — For patients and their families navigating the often confusing world of medical technology, the word “printing” usually means…
-
Johns Hopkins solves gut toxin mystery, opening cancer treatment path
NEW YORK, July 17 — A scientific discovery more than 15 years in the making is opening a fresh front in the…
-
Frederick Banting: Co-Discoverer of Insulin, Nobel Laureate
TORONTO, July 16 — Frederick Banting died in a plane crash in Newfoundland in 1941, but the insulin he helped drag out…
-
CBT for Insomnia Offers a Drug-Free Alternative to Sleeping Pills, Experts Say
WASHINGTON, July 16 — A strategic shift in the clinical approach to insomnia is underway, with cognitive behavioral therapy, not pills, now…
-
Opioid Crisis Moved From Painkillers to Heroin to Fentanyl in Waves, Study Finds
WASHINGTON, July 16 — The opioid epidemic, described by doctors and researchers as “one of the most devastating public health catastrophes of…
-
Down Syndrome-Alzheimer’s Link: Chromosome 21’s Role in Amyloid Buildup
ISLAMABAD, July 16 — A major medical conference later this year is set to put a spotlight on a long-recognised but still…
-
Emotional Dysregulation in Children and Teens: Causes, Warning Signs and Related Conditions
MANILA — For families across Asia, a child’s explosive tantrum or a teenager’s sudden withdrawal can feel bewildering. But for many, these…
-
Drug-Resistant Bacteria: How Antibiotic Success Fed the Superbug Problem
ISLAMABAD, July 8 — The story of antibiotics is one of modern medicine’s greatest triumphs, a narrative of lives snatched back from…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
How insulin went from dog experiments in 1921 to modern diabetes treatment
WASHINGTON, July 16 — The Association for Diagnostics & Laboratory Medicine, the global scientific and medical professional organization formerly known as the…
-
Alzheimer’s Amyloid Beta Explained: How Plaques Form and Two New Blood Tests Detect Them
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
Indiana Study Links Bowel Cancer Treatment Delays of 47 Days or More to Higher Spread Risk
BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…
-
Colorectal cancer is rising in adults under 50 as many patients are told they are too young
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
-
Large U.S. Study Links Cannabis Use Disorder to Nearly Four Times the Lung Cancer Risk
WASHINGTON, July 15 — A new case-control study, the largest of its kind ever conducted in the United States, has delivered a…
-
Ernexa Plans Fourth-Quarter First-in-Human Trial of ERNA-101 in Ovarian Cancer
SAN FRANCISCO, July 15 — Ernexa Therapeutics, a biotechnology company operating in the U.S. healthcare sector, is preparing to advance its lead…
-
Ernexa Moves ERNA-101 Into GMP Manufacturing Ahead of Planned IND Filing
KARACHI, July 15 — Ernexa Therapeutics is moving toward a planned first-in-human Phase 1 study for its lead cancer candidate, ERNA-101, though…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992